ALNY Snapshot
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts.
VALUATION DATA
Market Capitalization$16,503,742,000
Price to Sales22.03
Earnings per Share$-7.1300
PE RatioNone
PRICE DATA
Most Recent Close$138.3100
52 Week High$212
52 Week Low$125.08
50-Day Moving Average$174.53
200-Day Moving Average$172.59
All data are from Alpha Vantage as of today. For more infomation on ALNY see Stock Dividend, Valuation, Price and Financial Data for Investors